86 related articles for article (PubMed ID: 2927179)
1. Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French-American-British (FAB) Cooperative Group criteria.
Nakamura H
Leukemia; 1989 Apr; 3(4):305-9. PubMed ID: 2927179
[TBL] [Abstract][Full Text] [Related]
2. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
[TBL] [Abstract][Full Text] [Related]
3. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
4. [Cytogenetic findings in acute myelogenous leukemias (FAB M 1 to M 6)].
Prösch U; Stobbe H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):481-94. PubMed ID: 2414178
[TBL] [Abstract][Full Text] [Related]
5. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
Goldberg SL; Noel P; Klumpp TR; Dewald GW
Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
[TBL] [Abstract][Full Text] [Related]
6. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19.
Cigudosa JC; Odero MD; Calasanz MJ; Solé F; Salido M; Arranz E; Martínez-Ramirez A; Urioste M; Alvarez S; Cervera JV; MacGrogan D; Sanz MA; Nimer SD; Benitez J
Genes Chromosomes Cancer; 2003 Apr; 36(4):406-12. PubMed ID: 12619165
[TBL] [Abstract][Full Text] [Related]
7. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
Olopade OI; Thangavelu M; Larson RA; Mick R; Kowal-Vern A; Schumacher HR; Le Beau MM; Vardiman JW; Rowley JD
Blood; 1992 Dec; 80(11):2873-82. PubMed ID: 1450412
[TBL] [Abstract][Full Text] [Related]
8. [Evolution to megakaryoblastic leukemia observed in myelodysplastic syndrome with erythrolekemia-like features].
Takai K; Sanada M; Shibuya H
Rinsho Ketsueki; 1992 Aug; 33(8):1071-6. PubMed ID: 1404864
[TBL] [Abstract][Full Text] [Related]
9. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
10. Chromosome examinations on a six-hour culture of unstimulated peripheral blood from a patient with childhood erythroleukaemia.
Selypes A; László A; Virág I
Haematologia (Budap); 1989; 22(1):19-24. PubMed ID: 2707646
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
12. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
13. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and clinical assessment of six patients with erythroleukemia.
Trent JM; Durie BG; Davis JR; Veomett I
Anticancer Res; 1983; 3(2):111-6. PubMed ID: 6573867
[TBL] [Abstract][Full Text] [Related]
15. High-resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia.
Yunis JJ; Brunning RD; Howe RB; Lobell M
N Engl J Med; 1984 Sep; 311(13):812-8. PubMed ID: 6472383
[TBL] [Abstract][Full Text] [Related]
16. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
[TBL] [Abstract][Full Text] [Related]
17. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE
Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic study of a case of childhood erythroleukemia.
Duarte MH; Tone LG; Soares LR; dos Santos SA
Cancer Genet Cytogenet; 1990 Oct; 49(1):25-30. PubMed ID: 2397470
[TBL] [Abstract][Full Text] [Related]
19. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
Michalova K; Musilova J; Zemanova Z
Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
[TBL] [Abstract][Full Text] [Related]
20. 5q-anomaly in a patient with erythroleukemia (M6-FAB classification).
Donti E; Mecucci C; Rosetti A; Tabilio A; Venti G
Haematologica; 1985; 70(5):424-7. PubMed ID: 3937779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
